American College of Clinical Pharmacy
      Search      Cart
         

Clinical Reasoning Series–Pain, Agitation, and Delirium in the Intensive Care Unit Program to Offer 6.0 Hours of BCPS Recertification Credit

From Theory to Bedside: Clinical Reasoning Series

PAIN, AGITATION, AND DELIRIUM IN THE INTENSIVE CARE UNIT

From Theory to Bedside: Clinical Reasoning Series

Saturday, October 12, 2013
8:30 a.m.–4:30 p.m.

ACCP 2013 Annual Meeting * October 13-16, 2013 * Albuquerque, New Mexico

About From Theory to Bedside: Clinical Reasoning Series
From Theory to Bedside: Clinical Reasoning Series is one component of the professional development program developed by ACCP and approved by the Board of Pharmacy Specialties (BPS) for the recertification of the Board Certified Pharmacotherapy Specialist (BCPS).

This live education series explores cutting-edge, contemporary therapeutic topics, and demonstrates scientifically sound clinical reasoning and decision-making. It provides participants with active learning exercises designed to advance their skills and abilities to critically evaluate scientific evidence and clinical trials and to effectively incorporate into daily practice significant findings that lead to effective and safe patient care.

More information on the BCPS recertification professional development program is available at www.accp.com/careers/boardbcps.aspx.

Activity Overview
“Pain, Agitation, and Delirium in the Intensive Care Unit” will provide an overview of contemporary strategies for the assessment and optimal management of pain, agitation, and delirium that help inform patient care decisions.

Target Audience
Clinical pharmacists and BCPSs seeking recertification credit by continuing education

Continuing Pharmacy Education Credit
ACPE

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

This is an application-based activity; Activity Number: 0217-0000-13-110-L01-P.

To earn continuing pharmacy education credit and to receive your continuing pharmacy education statement of credit for this activity, participants must attend all 6.0 contact hours of programming and complete the associated evaluation at www.accp.com/ce. Partial credit is not available for this activity.

BCPS Recertification Credit
To be eligible for 6.0 CPE hours of recertification credit, BCPSs must attend all 6.0 contact hours of live programming and successfully complete a Web-based posttest by November 30, 2013. Partial credit is not available for this activity.

Learning Objectives
Upon completion of this activity, participants will be able to:

  1. Compare and contrast the various agents and strategies used in the management of pain, agitation, and delirium (PAD) in the intensive care unit (ICU).
  2. Use validated scales to assess, monitor, and optimize the management of PAD in the ICU.
  3. Incorporate screening tools to recognize delirium in the ICU.
  4. Develop an evidence-based plan for the optimal management of PAD in the ICU.
  5. Incorporate pharmacoeconomic principles to guide patient care decisions.
  6. Apply 2013 PAD guideline recommendations to clinical practice.
Agenda
8:30 a.m. Introduction
8:45 a.m. Optimizing Analgesia in the Critically Ill
10:15 a.m. Break
10:30 a.m. Optimizing the Use of Sedatives in the ICU: An Evidence-Based Approach
Noon Lunch
1:30 p.m. Approaches to the Prevention, Identification, and Management of Delirium
3:00 p.m. Break
3:15 p.m. Patient Cases and Panel Discussion
4:15 p.m. Closing Remarks

Learning objectives for each of the sessions are available at www.accp.com/meetings/am13/.

Program Faculty
Asad Patanwala Asad Patanwala, Pharm.D., BCPS
Associate Professor
University of Arizona College of Pharmacy
Emergency Medicine Pharmacist
University of Arizona Medical Center
Tucson, Arizona
Lee Skrupky, Pharm.D., BCPS Lee Skrupky, Pharm.D., BCPS
Clinical Pharmacist
Surgery, Trauma, Burn ICU
Barnes-Jewish Hospital
St. Louis, Missouri
Joanna Stollings, Pharm.D., BCPS Joanna Stollings, Pharm.D., BCPS
MICU Clinical Pharmacy Specialist
Delirium and Cognitive Impairment Study Group Pharmacist
Vanderbilt University Medical Center
Nashville, Tennessee

Program Reviewers
John W. Devlin, Pharm.D., FCCM, FCCP
Professor, Department of Pharmacy Practice
Bouve College of Health Sciences
Northeastern University
Boston, Massachusetts

Douglas Jennings, Pharm.D., BCPS (AQ Cardiology)
Clinical Pharmacy Specialist, Cardiothoracic Transplantation and Mechanical
Circulatory Support
Program Director, Pharmacotherapy Residency
Henry Ford Hospital
Department of Pharmacy Services
Detroit, Michigan

Ishaq Lat, PharmD, FCCM, FCCP, BCPS
Chair, Critical Care Pharmacotherapy Trials Network
Clinical Coordinator, Critical Care
Director, PGY2 Critical Care Pharmacy Residency
Department of Pharmaceutical Services
University of Chicago Medicine
Chicago, Illinois

Registration Fee

  Early
(September 6)
Late
(September 27)
On-site
ACCP Member $200 $255 $295
Nonmember $315 $370 $410

Registration fee includes program booklet, CPE credit, and access to the BCPS recertification posttest.

Full information on the agenda, learning objectives, faculty, and registration is available at www.accp.com/meetings/am13/.

No commercial support has been received for this activity.

Cookies

This website uses cookies to help ACCP provide you with the best user experience. If you continue to use our services, ACCP will assume that you agree to the use of such cookies. You can find out how to update your settings by referring to ACCP’s Policy on Cookies.